debrisoquin and desmethylselegiline

debrisoquin has been researched along with desmethylselegiline in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anttila, M; Bertilsson, L; Dahl, ML; Karnani, H; Nyman, L; Pelkonen, O; Scheinin, H; Taavitsainen, P1

Trials

1 trial(s) available for debrisoquin and desmethylselegiline

ArticleYear
CYP2D6 polymorphism is not crucial for the disposition of selegiline.
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:4

    Topics: Adrenergic Agents; Adult; Amphetamines; Area Under Curve; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans; In Vitro Techniques; Male; Methamphetamine; Microsomes, Liver; Monoamine Oxidase Inhibitors; Polymorphism, Genetic; Reference Values; Selegiline

1998